"acc/aha/acep/naemsp/scai guideline (2025): acute coronary syndromes" MCQ (SBA): STEMI

Instant feedback + full explanation. One question, done properly.

A 68-year-old post-PCI for STEMI is intolerant to ticagrelor (dyspnea). Best alternative P2Y12 inhibitor?

Educational content. Not a substitute for clinical judgement or local policy.

"acc/aha/acep/naemsp/scai guideline (2025): acute coronary syndromes"